Scinai (SCNI) news
Recent news
Scinai Immunotherapeutics announces $4.0 million financing through a private placement and warrant inducement
AInvest Wire · 22h agoScinai Immunotherapeutics - Potential additional clinical manufacturing indicative value $5.85 mln for late 2027-H1 2028
Scinai Immunotherapeutics is reportedly positioned to generate an additional clinical manufacturing indicative value of approximately $5.85 million during the late 2027 to first half of 2028 timeframe. This projection reflects potential revenue tied to the company’s ongoing clinical development and…
AInvest Wire · 1d agoScinai Immunotherapeutics - Agreement supports development in 2026 and clinical manufacturing in 2027
AInvest Wire · 1d agoScinai expands CDMO business with $5.1 million development and clinical manufacturing agreement
AInvest Wire · 1d agoScinai Immunotherapeutics: Registers 2.7 mln ADS representing 108.26 bln ordinary shares for sale by selling shareholder - SEC filing
Scinai Immunotherapeutics Ltd. (SCNI) has registered 2.7 million American Depositary Shares (ADS) for sale by a selling shareholder, representing 108.26 billion ordinary shares , according to a recent SEC filing. The registration is part of a standard process to facilitate the public resale of…
AInvest Wire · Sep 24, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.